Berman Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Berman Capital Advisors's LLY Position: Q3 2021 in Review
Berman Capital Advisors increased its Eli Lilly (LLY) stake by 13% in Q3 2021, buying an estimated $119K and bringing the position to 4,142 shares worth $956K. The position accounts for 0.15% of the portfolio, ranked #76.
Berman Capital Advisors first reported a position in LLY in Q4 2018 and has held it in 12 quarters since. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.
- Berman Capital Advisors held 4,142 shares of Eli Lilly worth $956K as of Q3 2021.
- Berman Capital Advisors bought 482 Eli Lilly shares in Q3 2021, an estimated $119K.
- Eli Lilly made up 0.15% of Berman Capital Advisors's portfolio in Q3 2021, its #76 holding.
- Berman Capital Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 12 quarters since.
- 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.